BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7927535)

  • 1. The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia.
    Rohrer J; Parolini O; Belmont JW; Conley ME; Parolino O [corrected to Parolini O]
    Immunogenetics; 1994; 40(5):319-24. PubMed ID: 7927535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.
    Hagemann TL; Chen Y; Rosen FS; Kwan SP
    Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci.
    Sideras P; Müller S; Shiels H; Jin H; Khan WN; Nilsson L; Parkinson E; Thomas JD; Brandén L; Larsson I
    J Immunol; 1994 Dec; 153(12):5607-17. PubMed ID: 7989760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase.
    Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J
    Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
    Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
    J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency.
    Duriez B; Duquesnoy P; Dastot F; Bougnères P; Amselem S; Goossens M
    FEBS Lett; 1994 Jun; 346(2-3):165-70. PubMed ID: 8013627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia.
    Ohta Y; Haire RN; Litman RT; Fu SM; Nelson RP; Kratz J; Kornfeld SJ; de la Morena M; Good RA; Litman GW
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9062-6. PubMed ID: 8090769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.
    Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI
    Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
    Saha BK; Curtis SK; Vogler LB; Vihinen M
    Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.
    Schuster V; Seidenspinner S; Kreth HW
    Am J Med Genet; 1996 May; 63(1):318-22. PubMed ID: 8723128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sixty-nine kilobases of contiguous human genomic sequence containing the alpha-galactosidase A and Bruton's tyrosine kinase loci.
    Oeltjen JC; Liu X; Lu J; Allen RC; Muzny D; Belmont JW; Gibbs RA
    Mamm Genome; 1995 May; 6(5):334-8. PubMed ID: 7626884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of mutations, including a novel regulatory defect in the first intron, in Bruton's tyrosine kinase gene from seven Korean X-linked agammaglobulinemia families.
    Jo EK; Kanegane H; Nonoyama S; Tsukada S; Lee JH; Lim K; Shong M; Song CH; Kim HJ; Park JK; Miyawaki T
    J Immunol; 2001 Oct; 167(7):4038-45. PubMed ID: 11564824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
    Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T
    Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.
    Brooimans RA; van den Berg AJ; Rijkers GT; Sanders LA; van Amstel JK; Tilanus MG; Grubben MJ; Zegers BJ
    J Med Genet; 1997 Jun; 34(6):484-8. PubMed ID: 9192269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
    Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
    Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.
    Holinski-Feder E; Weiss M; Brandau O; Jedele KB; Nore B; Bäckesjö CM; Vihinen M; Hubbard SR; Belohradsky BH; Smith CI; Meindl A
    Pediatrics; 1998 Feb; 101(2):276-84. PubMed ID: 9445504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
    Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
    Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia.
    Vorechovský I; Luo L; Hertz JM; Frøland SS; Klemola T; Fiorini M; Quinti I; Paganelli R; Ozsahin H; Hammarström L; Webster AD; Smith CI
    Hum Mutat; 1997; 9(5):418-25. PubMed ID: 9143921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
    de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
    Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
    Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI
    J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.